Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

674 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.
Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, Beger H, Fernandez-Cruz L, Dervenis C, Lacaine F, Falconi M, Pederzoli P, Pap A, Spooner D, Kerr DJ, Büchler MW; European Study Group for Pancreatic Cancer. Neoptolemos JP, et al. Among authors: beger h. N Engl J Med. 2004 Mar 18;350(12):1200-10. doi: 10.1056/NEJMoa032295. N Engl J Med. 2004. PMID: 15028824 Free article. Clinical Trial.
Progress report. A randomized multicenter European study comparing adjuvant radiotherapy, 6-mo chemotherapy, and combination therapy vs no-adjuvant treatment in resectable pancreatic cancer (ESPAC-1).
Neoptolemos JP, Baker P, Beger H, Link K, Pederzoli P, Bassi C, Dervenis C, Friess H, Büchler M. Neoptolemos JP, et al. Among authors: beger h. Int J Pancreatol. 1997 Apr;21(2):97-104. doi: 10.1007/BF02822380. Int J Pancreatol. 1997. PMID: 9209950 Clinical Trial.
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial.
Neoptolemos JP, Dunn JA, Stocken DD, Almond J, Link K, Beger H, Bassi C, Falconi M, Pederzoli P, Dervenis C, Fernandez-Cruz L, Lacaine F, Pap A, Spooner D, Kerr DJ, Friess H, Büchler MW; European Study Group for Pancreatic Cancer. Neoptolemos JP, et al. Among authors: beger h. Lancet. 2001 Nov 10;358(9293):1576-85. doi: 10.1016/s0140-6736(01)06651-x. Lancet. 2001. PMID: 11716884 Clinical Trial.
Patient-centered developments in colon- and rectal cancer with a multidisciplinary international team: From translational research to national guidelines.
Link KH, Kornmann M, Staib L, Kreuser ED, Gaus W, Röttinger E, Suhr P, Maulbecker-Armstrong C, Danenberg P, Danenberg K, Schatz M, Sander S, Ji ZL, Li JT, Peng SY, Bittner R, Beger HG, Traub B. Link KH, et al. Among authors: beger hg. World J Gastrointest Surg. 2021 Dec 27;13(12):1597-1614. doi: 10.4240/wjgs.v13.i12.1597. World J Gastrointest Surg. 2021. PMID: 35070066 Free PMC article. Review.
F-18 Fluorodeoxyglucose (FDG) and C-Reactive Protein (CRP).
Diederichs CG, Staib L, Glasbrenner B, Guhlmann A, Glatting G, Pauls S, Beger HG, Reske SN. Diederichs CG, et al. Clin Positron Imaging. 1999 May;2(3):131-136. doi: 10.1016/s1095-0397(99)00019-9. Clin Positron Imaging. 1999. PMID: 14516536
[Prognostic factors in pancreatic carcinoma].
Beger HG. Beger HG. Langenbecks Arch Chir. 1995;380(3):131-2. doi: 10.1007/BF00207716. Langenbecks Arch Chir. 1995. PMID: 7791481 German. No abstract available.
[Gallstone therapy--cooperation or competition?].
Beger HG. Beger HG. Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir. 1990:1189-91. Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir. 1990. PMID: 1983510 German.
674 results